MERIT MEDICAL SYSTEMS INC (MMSI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 150M 300M 450M Q3 '21: 267M Q4 '21: 278.5M Q1 '22: 275.4M Q2 '22: 295M Q3 '22: 287.2M Q4 '22: 293.4M Q1 '23: 297.6M Q2 '23: 320.1M Q3 '23: 315.2M Q4 '23: 324.5M Q1 '24: 323.5M Q2 '24: 338M Q3 '24: 339.8M Q4 '24: 355.2M Q1 '25: 355.4M Q2 '25: 382.5M Q3 '25: 384.2M Q4 '25: 393.9M Q1 '26: 381.9M Q2 '26: 418.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 80M 160M 240M Q3 '21: 120.5M Q4 '21: 128.8M Q1 '22: 120.9M Q2 '22: 135.1M Q3 '22: 128.6M Q4 '22: 134.6M Q1 '23: 138.4M Q2 '23: 152.8M Q3 '23: 142.2M Q4 '23: 150.5M Q1 '24: 151.7M Q2 '24: 161.1M Q3 '24: 157.5M Q4 '24: 173M Q1 '25: 172M Q2 '25: 184.5M Q3 '25: 186.4M Q4 '25: 195.4M Q1 '26: 184.8M Q2 '26: 215.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

0 25M 50M 75M Q3 '21: 15.9M Q4 '21: 21.9M Q1 '22: 15.2M Q2 '22: 23.3M Q3 '22: 18.7M Q4 '22: 30.4M Q1 '23: 26.4M Q2 '23: 28.8M Q3 '23: 35.1M Q4 '23: 33.6M Q1 '24: 35.9M Q2 '24: 45.9M Q3 '24: 37.3M Q4 '24: 36.6M Q1 '25: 41M Q2 '25: 46.9M Q3 '25: 42.6M Q4 '25: 54.2M Q1 '26: 44.2M Q2 '26: 60.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

0 15M 30M 45M Q3 '21: 12M Q4 '21: 20.6M Q1 '22: 10.5M Q2 '22: 15.3M Q3 '22: 15.3M Q4 '22: 33.4M Q1 '23: 20.7M Q2 '23: 20.2M Q3 '23: 25.8M Q4 '23: 27.6M Q1 '24: 28.2M Q2 '24: 35.7M Q3 '24: 28.4M Q4 '24: 27.9M Q1 '25: 30.1M Q2 '25: 32.6M Q3 '25: 27.8M Q4 '25: 38M Q1 '26: 41M Q2 '26: 38.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 70M 140M 210M Q3 '21: 146.5M Q4 '21: 149.7M Q1 '22: 154.5M Q2 '22: 159.9M Q3 '22: 158.6M Q4 '22: 158.9M Q1 '23: 159.2M Q2 '23: 167.3M Q3 '23: 173M Q4 '23: 174M Q1 '24: 171.8M Q2 '24: 176.9M Q3 '24: 182.3M Q4 '24: 182.2M Q1 '25: 183.3M Q2 '25: 198M Q3 '25: 197.7M Q4 '25: 198.6M Q1 '26: 197.1M Q2 '26: 203.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

0 35M 70M 105M Q3 '21: 25M Q4 '21: 45.8M Q1 '22: 12M Q2 '22: 38.8M Q3 '22: 35.5M Q4 '22: 28M Q1 '23: 14.5M Q2 '23: 17.3M Q3 '23: 51.1M Q4 '23: 62.3M Q1 '24: 36.2M Q2 '24: 68.5M Q3 '24: 47.3M Q4 '24: 68.7M Q1 '25: 40.6M Q2 '25: 83.3M Q3 '25: 75M Q4 '25: 98.5M Q1 '26: 40.7M Q2 '26: 69.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

0 30M 60M 90M Q3 '21: 18.2M Q4 '21: 37.5M Q1 '22: 2.5M Q2 '22: 31.5M Q3 '22: 19.7M Q4 '22: 15.5M Q1 '23: 1.8M Q2 '23: 11.5M Q3 '23: 42.5M Q4 '23: 55.1M Q1 '24: 24.5M Q2 '24: 57.9M Q3 '24: 38M Q4 '24: 65.3M Q1 '25: 19.5M Q2 '25: 69.6M Q3 '25: 52.5M Q4 '25: 74M Q1 '26: 24.7M Q2 '26: 51.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q1 '20: 55.2M Q2 '20: 55.4M Q3 '20: 55.5M Q1 '21: 57M Q2 '21: 57.3M Q3 '21: 57.5M Q1 '22: 57.5M Q2 '22: 57.6M Q3 '22: 57.6M Q1 '23: 58.2M Q2 '23: 58.5M Q3 '23: 58.4M Q1 '24: 58.6M Q2 '24: 58.7M Q3 '24: 59.5M Q1 '25: 61.3M Q2 '25: 60.6M Q3 '25: 59.9M Q1 '26: 60M Q2 '26: 60M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.90 1.80 2.70 Q3 '21: 0.76 Q4 '21: 0.84 Q1 '22: 0.83 Q2 '22: 1.01 Q3 '22: 1.07 Q4 '22: 1.30 Q1 '23: 1.48 Q2 '23: 1.56 Q3 '23: 1.73 Q4 '23: 1.63 Q1 '24: 1.75 Q2 '24: 2.01 Q3 '24: 2.05 Q4 '24: 2.03 Q1 '25: 2.04 Q2 '25: 1.97 Q3 '25: 1.95 Q4 '25: 2.13 Q1 '26: 2.32 Q2 '26: 2.43 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.